about
Pharmacokinetics and pharmacodynamics of SCT800, a new recombinant FVIII, in hemophilia A mice.Quality laboratory issues in bleeding disorders.Factor IX-deficient plasma spiked with N9-GP behaves similarly to N9-GP post-administration clinical samples in N9-GP ELISA and FIX activity assays.Factor VIII chromogenic assays can be used for potency labeling and postadministration monitoring of N8-GP.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Chromogenic factor VIII activity assay.
@en
type
label
Chromogenic factor VIII activity assay.
@en
prefLabel
Chromogenic factor VIII activity assay.
@en
P2860
P356
P1476
Chromogenic factor VIII activity assay.
@en
P2093
Dorothy M Adcock Funk
Karen A Moser
P2860
P304
P356
10.1002/AJH.23723
P577
2014-04-15T00:00:00Z